Skip to main content
. 2019 Jun 4;4(2):89. doi: 10.3390/tropicalmed4020089
ACT artemisinin combination therapy
ALLN N-acetyl-L-leucyl-L-norleucinal
AQ amodiaquine
ART artemisinin
ARTR/S artemisinin resistant/sensitive
ATM artemether
ATS artesunate
BiPY 2,2′-bipyridyl
DCP delayed clearance phenotype
DFO Deferoxamine
DFP Deferiprone
DHA Dihydroartemisinin
DV digestive vacuole
EPR electron paramagnetic resonance
ER endoplasmic reticulum
FPIX ferriprotoporphyrin IX heme
ggcs, gamma glutamylcysteine synthetase
GSH glutathione
GSSG glutathione disulfide
GWAS genome-wide association study
Hb hemoglobin
Hz hemozoin
IC50 half-maximal inhibitory concentration
iRBC infected red blood cell
LD50 half-maximal lethal concentration
LF lumefantrine
MOA mechanism of action
MQ mefloquine
MRP multidrug resistance protein
MS mass spectrometry
PfPI3K Plasmodium falciparum phosphatidyl-3′-kinase
PPQ piperaquine
RSA ring stage assay
SDS-PAGE sodium dodecyl sulfate-polyacrylamide gel electrophoresis
SEA Southeast Asia
SNP single nucleotide polymorphism
QTL quantitative trait locus